Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of the 24-Hour Intragastric pH Profile After 5 Days of Once Daily Oral Administration of Either Esomeprazole 40 Mg or Pantoprazole 40 Mg Following Once Daily Infusion of Intravenous Pantoprazole 40 Mg for 5 Days in Healthy Volunteer Subjects

Next Previous
Search
Trial Profile

A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of the 24-Hour Intragastric pH Profile After 5 Days of Once Daily Oral Administration of Either Esomeprazole 40 Mg or Pantoprazole 40 Mg Following Once Daily Infusion of Intravenous Pantoprazole 40 Mg for 5 Days in Healthy Volunteer Subjects

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Apr 2009

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Esomeprazole (Primary) ; Pantoprazole; Pantoprazole
  • Indications Gastro-oesophageal reflux
  • Focus Pharmacodynamics
  • Sponsors AstraZeneca

Most Recent Events

  • 09 Sep 2008 New trial record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top